These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21501602)

  • 1. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus.
    Weingärtner O; Lütjohann D; Vanmierlo T; Müller S; Günther L; Herrmann W; Böhm M; Laufs U; Herrmann M
    Chem Phys Lipids; 2011 Sep; 164(6):451-6. PubMed ID: 21501602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis.
    Weingärtner O; Weingärtner N; Scheller B; Lütjohann D; Gräber S; Schäfers HJ; Böhm M; Laufs U
    Coron Artery Dis; 2009 Sep; 20(6):376-82. PubMed ID: 19620855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plant sterol deposition in vascular tissue characterizes patients with severe aortic stenosis and concomitant coronary artery disease.
    Luister A; Schött HF; Husche C; Schäfers HJ; Böhm M; Plat J; Gräber S; Lütjohann D; Laufs U; Weingärtner O
    Steroids; 2015 Jul; 99(Pt B):272-80. PubMed ID: 25814070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Campesterol Is Positively Associated with Carotid Plaques in Asymptomatic Subjects.
    Nunes VS; de Campos EVS; Baracat J; França V; Gomes ÉIL; Coelho RP; Nakandakare ER; Zago VHS; de Faria EC; Quintão ECR
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.
    Brindisi MC; Guiu B; Duvillard L; Athias A; Rollot F; Bouillet B; Beacco M; Hillon P; Cercueil JP; Verges B; Petit JM
    Atherosclerosis; 2012 Oct; 224(2):465-8. PubMed ID: 22959662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular disease.
    Smahelová A; Hyspler R; Haas T; Tichá A; Bláha V; Zadák Z
    Pharmacol Res; 2005 Jan; 51(1):31-6. PubMed ID: 15519532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy.
    Mori K; Ishida T; Tsuda S; Oshita T; Shinohara M; Hara T; Irino Y; Toh R; Hirata KI
    J Atheroscler Thromb; 2017 Feb; 24(2):123-132. PubMed ID: 27487947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk.
    Weingärtner O; Lütjohann D; Böhm M; Laufs U
    Atherosclerosis; 2010 Jun; 210(2):362-5. PubMed ID: 20116793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.
    Matthan NR; Pencina M; LaRocque JM; Jacques PF; D'Agostino RB; Schaefer EJ; Lichtenstein AH
    J Lipid Res; 2009 Sep; 50(9):1927-35. PubMed ID: 19436064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.
    Bláha V; Andrýs C; Smahelová A; Knízek J; Hyspler R; Solichová D; Bláha M; Zadák Z
    Pharmacol Res; 2006 Dec; 54(6):421-8. PubMed ID: 17011788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
    Gojkovic T; Vladimirov S; Spasojevic-Kalimanovska V; Zeljkovic A; Vekic J; Kalimanovska-Ostric D; Djuricic I; Sobajic S; Jelic-Ivanovic Z
    Clin Chem Lab Med; 2017 Mar; 55(3):447-457. PubMed ID: 27718480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Add-on" effect of phytosterols-enriched fermented milk on lipids and markers of cholesterol metabolism in statin-treated elderly patients.
    Andrade I; Santos L; Ramos F
    Steroids; 2015 Jul; 99(Pt B):293-8. PubMed ID: 25796548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia.
    Lupattelli G; Siepi D; De Vuono S; Roscini AR; Crisanti F; Covelli D; Pirro M; Mannarino E
    Life Sci; 2012 Jun; 90(21-22):846-50. PubMed ID: 22554491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.
    Semova I; Levenson AE; Krawczyk J; Bullock K; Williams KA; Wadwa RP; Shah AS; Khoury PR; Kimball TR; Urbina EM; de Ferranti SD; Bishop FK; Maahs DM; Dolan LM; Clish CB; Biddinger SB
    J Clin Lipidol; 2019; 13(6):940-946. PubMed ID: 31706902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.
    Matthan NR; Zhu L; Pencina M; D'Agostino RB; Schaefer EJ; Lichtenstein AH
    J Am Heart Assoc; 2013 Feb; 2(1):e005066. PubMed ID: 23525441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function, cholesterol absorption and remnant lipoprotein accumulation in patients with diabetes mellitus.
    Sonoda M; Shoji T; Kimoto E; Okute Y; Shima H; Naganuma T; Motoyama K; Morioka T; Mori K; Fukumoto S; Shioi A; Koyama H; Emoto M; Inaba M
    J Atheroscler Thromb; 2014; 21(4):346-54. PubMed ID: 24335047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.
    Barbosa SP; Lins LC; Fonseca FA; Matos LN; Aguirre AC; Bianco HT; Amaral JB; França CN; Santana JM; Izar MC
    Life Sci; 2013 May; 92(14-16):845-51. PubMed ID: 23507424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.